Antonin Berger is an experienced professional in the fields of computer systems validation and lab automation, with a notable background in the life sciences and biomedical engineering sectors. At Novo Nordisk, Antonin served as a Computer Systems Validation Engineer, focusing on the implementation and revamp of GMP-compliant systems. Following that role, Antonin worked at Nobel Biocare, ensuring compliance with biocompatibility and biomechanics standards, before transitioning to Merck Group, where automation of DSP chromatography robotics was a key responsibility. Currently, Antonin is part of the Roche Pharma Early Research and Development department, developing a global automation strategy. Antonin holds a Bachelor of Science degree in Life Sciences Engineering from Ecole polytechnique fédérale de Lausanne and is pursuing advanced degrees in Biomedical Engineering from the University of Oxford and Medical Technologies at ETH Zürich.
This person is not in the org chart
This person is not in any teams
This person is not in any offices